<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.0//EN" "ep-patent-document-v1-0.dtd"><ep-patent-document id="EP03819151A2" file="03819151.6" lang="en" country="EP" doc-number="1631311" kind="A2" date-publ="20060308" status="n" dtd-version="ep-patent-document-v1-01"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHU..SK................</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>DIM360 (Ver 1.5  21 Nov 2005) -  1100000/0 1710000/0</B007EP></eptags></B000><B100><B110>1631311</B110><B130>A2</B130><B140><date>20060308</date></B140><B190>EP</B190></B100><B200><B210>03819151.6</B210><B220><date>20031210</date></B220><B240><B241><date>20051214</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B400><B405><date>20060308</date><bnum>200610</bnum></B405><B430><date>20060308</date><bnum>200610</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  39/395       19850101AFI20051228BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>HUMANISIERTE ANTI-CCR2-ANTIKÖRPER UND ANWENDUNGSVERFAHREN</B542><B541>en</B541><B542>HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE</B542><B541>fr</B541><B542>ANTICORPS HUMANISES ANTI-CCR2 ET LEURS PROCEDES D'UTILISATION</B542></B540></B500><B700><B710><B711><snm>MILLENNIUM PHARMACEUTICALS, INC.</snm><iid>02078691</iid><irf>EPP290565</irf><adr><str>75 Sidney Street</str><city>Cambridge, MA 02139-4169</city><ctry>US</ctry></adr></B711></B710><B720><B721><snm>O'KEEFE, Theresa</snm><adr><str>20 Richgrain Avenue</str><city>Waltham, MA 02453</city><ctry>US</ctry></adr></B721><B721><snm>PONATH, Paul</snm><adr><str>698 Clipper Street</str><city>San Francisco, CA 94114</city><ctry>US</ctry></adr></B721></B720><B740><B741><snm>Williams, Gareth Owen</snm><iid>00126011</iid><adr><str>Marks &amp; Clerk 
66-68 Hills Road</str><city>Cambridge CB2 1LA</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry></B845EP><B845EP><ctry>LT</ctry></B845EP><B845EP><ctry>LV</ctry></B845EP><B845EP><ctry>MK</ctry></B845EP></B844EP><B860><B861><dnum><anum>US2003039599</anum></dnum><date>20031210</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2005060368</pnum></dnum><date>20050707</date><bnum>200527</bnum></B871></B870><B880><date>20051222</date><bnum>000000</bnum></B880></B800></SDOBI></ep-patent-document>